MITF and melanoma: The sensitivity of melanoma cells to BRAFi has been associated with a highly differentiated cell state under the control of the MITF transcription factor (i.e., MITFhigh or pigmentation signature) (Rose et al, 2016; Smith et al, 2016; Rambow et al, 2018).